Janne Backman, leads research on pharmacokinetics, drug-drug interactions and the molecular mechanisms causing them. Recent research has focused on drug-drug interactions caused by irreversible inhibition of the drug-metabolising cytochrome P450 (CYP) enzyme, the role of CYP2C8 in drug metabolism, and drug drug interactions of anticancer agents.
Collaboration and funding partners
Janne Backman, MD, PhD, professor
Janne Backman, MD, PhD, Professor in Clinical Pharmacology and Individual Medicine, is the head of the Department of Clinical Pharmacology and the principal investigator of a research group focusing on pharmacokinetics and drug-drug interactions.
Members of Group Backman
Current research members of Group Backman include:
- Janne Backman
- Aleksi Tornio
- Laura Aurinsalo
- Matti Itkonen
- Taavi Kaartinen
- Helinä Kahma
- Aleksi Olkkola
See People for more information.
Drug-drug interactions (video)
Prof. Backman talks about recognising and minimising the risk of drug-drug interactions.